GlaxoSmithkline, GlaxoSmithKline resignation, GlaxoSmithKline appointments, GlaxoSmithKline shares, GlaxoSmithKline Dividends, GlaxoSmithKline financial result
GlaxoSmithKline building

Glaxo Smithkline Consumer Nigeria Plc today released its financial statements for the period ended Q1 March 31st 2018.

Here are the key highlights of the results;

Revenue

The company reported Revenue of ₦4.21 billion for the period ended March 2018 compared to ₦3.85 billion reported for the period ended March 2017. This represents a 9% increase for the comparative period in 2017.

Profit Before Tax

Profit before tax was ₦368.99 million for the period ended March 2018 compared to a ₦8.26 million loss before tax reported for the period ended March 2017.

Profit After tax

The group’s profit after tax for the period ended March 2018 ₦258.29 million compared to  ₦8.26 million loss after tax reported March 2017.

Earnings Per Share 

Glaxo Smithkline Consumer Nigeria Plc also reported earnings per share of 22 kobo for the period ended March 2018 compared to 1 kobo loss per share reported for the period ended March 2017.

DOWNLOAD GLAXO SMITHKLINE CONSUMER NIGERIA PLC Q1 2018 RESULTS.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.